Your browser doesn't support javascript.
loading
Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.
Suetterlin, Karen Joan; Bugiardini, Enrico; Kaski, Juan P; Morrow, Jasper M; Matthews, Emma; Hanna, Michael G; Fialho, Doreen.
Afiliação
  • Suetterlin KJ; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
  • Bugiardini E; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
  • Kaski JP; University College London Institute of Cardiovascular Science, London, England.
  • Morrow JM; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
  • Matthews E; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
  • Hanna MG; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
  • Fialho D; MRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
JAMA Neurol ; 72(12): 1531-3, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26658970
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Canalopatias / Bloqueadores do Canal de Sódio Disparado por Voltagem / Mexiletina Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Canalopatias / Bloqueadores do Canal de Sódio Disparado por Voltagem / Mexiletina Idioma: En Ano de publicação: 2015 Tipo de documento: Article